HAROLD FLOCKHART: Open Payments
NPI 1093734139 · EAST SETAUKET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,304 in 139 payments from 22 companies in 2025. Trend: 2023 $2,861 · 2024 $2,421 · 2025 $3,304
Food & beverage: $3,103Education: $200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $667 |
| Janssen Biotech, Inc. | 11 | $349 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $341 |
| Lilly USA, LLC | 7 | $277 |
| Madrigal Pharmaceuticals | 6 | $264 |
| QOL Medical, LLC | 7 | $227 |
| AstraZeneca Pharmaceuticals LP | 9 | $157 |
| Ardelyx, Inc. | 7 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $145 |
| PFIZER INC. | 6 | $128 |
Products named: TREMFYA, XIFAXAN, SKYRIZI, REZDIFFRA, Sucraid, IBSRELA, ENTYVIO, RINVOQ.
Industry payments across NY — which companies pay providers there.
